Downregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference

Cellular Immunology

Volumn 294, Issue 1, 2015, Pages 44-53

  Chen, Swey Shen ^a,b,c   Sun, Liang Wu ^a,b   Brickner, Howard ^a,b   Sun, Pei Qing ^c  

^a The Institute of Genetics   (United States)

^b IgE Therapeutics Inc   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cytokines; Dendritic cells; Galectin 3; Inflammation; Innate immunity; Th17

Indexed keywords

CD45RO ANTIGEN; GALECTIN 3; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LENTIVIRUS VECTOR; NEUTRALIZING ANTIBODY; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; CYTOKINE; IL10 PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; IL23A PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; PATTERN RECOGNITION RECEPTOR;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HT 29 CELL LINE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MEMORY CELL; MONOCYTE DERIVED DENDRITIC CELL; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RNA INTERFERENCE; TH17 CELL; TH2 CELL; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; GENETICS; IMMUNOLOGY; INFLAMMATION;

CELL DIFFERENTIATION; CELL LINE; CYTOKINES; DENDRITIC CELLS; DOWN-REGULATION; GALECTIN 3; HT29 CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-1BETA; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKIN-6; RECEPTORS, PATTERN RECOGNITION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TH17 CELLS; TH2 CELLS;

EID: 84922967611     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2015.01.017     Document Type: Article

References (60)

1. Liu F.-T., Rabinovich G.A. Galectins: regulators of acute and chronic inflammation. Ann. N. Y. Acad. Sci. 2010, 1183:158-182.
2. Liu F.-T., Rabinovich G.A. Galectins as modulators of tumour progression. Nat. Rev. Cancer 2005, 5:29-41.
3. Demetriou M., Granovsky M., Quaggin S., Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5N-glycosylation. Nature 2001, 409:733-739.
4. Partridge E.A., Le Roy C., Di Guglielmo G.M., Pawling J., Cheung P., Granovsky M., Nabi I.R., Wrana J.L., Dennis J.W. Regulation of cytokine receptors by golgi N-glycan processing and endocytosis. Science 2004, 306:120-124.
5. Earl L.A., Bi S., Baum L.G. N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death. J. Biol. Chem. 2010, 285:2232-2244.
6. Henderson N.C., Mackinnon A.C., Farnworth S.L., Poirier F., Russo F.P., Iredale J.P., Haslett C., Simpson K.J., Sethi T. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5060-5065.
7. de Boer R.A., Voors A.A., Muntendam P., van Gilst W.H., van Veldhuisen D.J. Galectin-3: a novel mediator of heart failure development and progression. Eur. J. Heart Fail. 2009, 11:811-817.
8. Fukushi J.-I., Makagiansar I.T., Stallcup W.B. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and {alpha}3{beta}1 integrin. Mol. Biol. Cell 2004, 15:3580-3590.
9. Liu Y.-H., D'Ambrosio M., Liao T.-D., Peng H., Rhaleb N.-E., Sharma U., André S., Gabius H.-J., Carretero O.A. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin. Am. J. Physiol. Heart Circ. Physiol. 2009, 296. (H404-H412-H404-H412).
10. Weigert J., Neumeier M., Wanninger J., Bauer S., Farkas S., Scherer M.N., Schnitzbauer A., Schäffler A., Aslanidis C., Schölmerich J., Buechler C. Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. J. Clin. Endocrinol. Metab. 2010, 95:1404-1411.
11. Mahendran S., Sethi T. Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach?. QJM 2012, 105:929-934.
12. Cheong C., Matos I., Choi J.-H., Dandamudi D.B., Shrestha E., Longhi M.P., Jeffrey K.L., Anthony R.M., Kluger C., Nchinda G., Koh H., Rodriguez A., Idoyaga J., Pack M., Velinzon K., Park C.G., Steinman R.M. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209+ dendritic cells for immune T cell areas. Cell 2010, 143:416-429.
13. Plantinga M., Guilliams M., Vanheerswynghels M., Deswarte K., Branco-Madeira F., Toussaint W., Vanhoutte L., Neyt K., Killeen N., Malissen B., Hammad H., Lambrecht Bart N. Conventional and monocyte-derived CD11b+ dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 2013, 38:322-335.
14. Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 2009, 21:317-337.
15. Lambrecht B.N., Hammad H. Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu. Rev. Immunol. 2012, 30:243-270.
16. Geijtenbeek T.B.H., Gringhuis S.I. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 2009, 9:465-479.
17. Hollmig S.T., Ariizumi K., Cruz P.D. Recognition of non-self-polysaccharides by C-type lectin receptors dectin-1 and dectin-2. Glycobiology 2009, 19:568-575.
18. Rabinovich G.A., Toscano M.A. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2009, 9:338-352.
19. Zuberi R.I., Hsu D.K., Kalayci O., Chen H.-Y., Sheldon H.K., Yu L., Apgar J.R., Kawakami T., Lilly C.M., Liu F.-T. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am. J. Pathol. 2004, 165:2045-2053.
20. van Stijn C.M.W., van den Broek M., van de Weerd R., Visser M., Tasdelen I., Tefsen B., van Die I. Regulation of expression and secretion of galectin-3 in human monocyte-derived dendritic cells. Mol. Immunol. 2009, 46:3292-3299.
21. Liu F.T., Hsu D.K., Zuberi R.I., Hill P.N., Shenhav A., Kuwabara I., Chen S.S. Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains. Biochemistry 1996, 35:6073-6079.
22. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
23. Lombardi V., Van Overtvelt L., Horiot S., Moingeon P. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-{gamma}, and IL-17A by naive CD4+ T cells. J. Immunol. 2009, 182:3372-3379.
24. Kato M., Mcdonald K.J., Khan S., Ross I.L., Vuckovic S., Chen K., Munster D., MacDonald K.P.A., Hart D.N.J. Expression of human DEC-205 (CD205) multilectin receptor on leukocytes. Int. Immunol. 2006, 18:857-869.
25. O'Neill D.W., Bhardwaj N. Differentiation of peripheral blood monocytes into dendritic cells. Current Protocols in Immunology 2001, John Wiley & Sons Inc.
26. Annunziato F., Romagnani S. Do studies in humans better depict Th17 cells?. Blood 2009, 114:2213-2219.
27. Ghoreschi K., Laurence A., Yang X.-P., Tato C.M., McGeachy M.J., Konkel J.E., Ramos H.L., Wei L., Davidson T.S., Bouladoux N., Grainger J.R., Chen Q., Kanno Y., Watford W.T., Sun H.-W., Eberl G., Shevach E.M., Belkaid Y., Cua D.J., Chen W., O'Shea J.J. Generation of pathogenic TH17 cells in the absence of TGF-[bgr] signalling. Nature 2010, 467:967-971.
28. Yang L., Anderson D.E., Baecher-Allan C., Hastings W.D., Bettelli E., Oukka M., Kuchroo V.K., Hafler D.A. IL-21 and TGF-[bgr] are required for differentiation of human TH17 cells. Nature 2008, 454:350-352.
29. Barrett N.A., Maekawa A., Rahman O.M., Austen K.F., Kanaoka Y. Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells. J. Immunol. 2009, 182:1119-1128.
30. Hammad H., Chieppa M., Perros F., Willart M.A., Germain R.N., Lambrecht B.N. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 2009, 15:410-416.
31. Wei W.-C., Su Y.-H., Chen S.-S., Sheu J.-H., Yang N.-S. GM-CSF plays a key role in zymosan-stimulated human dendritic cells for activation of Th1 and Th17 cells. Cytokine 2011, 55:79-89.
32. Nyirenda M.H., Sanvito L., Darlington P.J., O'Brien K., Zhang G.-X., Constantinescu C.S., Bar-Or A., Gran B. TLR2 Stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. J. Immunol. 2011, 187:2278-2290.
33. van Beelen A.J., Zelinkova Z., Taanman-Kueter E.W., Muller F.J., Hommes D.W., Zaat S.A.J., Kapsenberg M.L., de Jong E.C. Stimulation of the intracellular bacterial sensor NOD2 Programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 2007, 27:660-669.
34. Liu L.Y., Mathur S.K., Sedgwick J.B., Jarjour N.N., Busse W.W., Kelly E.A.B. Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion. Allergy 2006, 61:589-597.
35. Mandron M., Ariès M.-F., Brehm R.D., Tranter H.S., Acharya K.R., Charveron M., Davrinche C. Human dendritic cells conditioned with Staphylococcus aureus enterotoxin B promote TH2 cell polarization. J. Allergy Clin. Immunol. 2006, 117:1141-1147.
36. Liu F.-T., Hsu D.K., Zuberi R.I., Hill P.N., Shenhav A., Kuwabara I., Chen S.-S. Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains†. Biochemistry 1996, 35:6073-6079.
37. Liu K., Victora G.D., Schwickert T.A., Guermonprez P., Meredith M.M., Yao K., Chu F.-F., Randolph G.J., Rudensky A.Y., Nussenzweig M. In vivo analysis of dendritic cell development and homeostasis. Science 2009, 324:392-397.
38. Dzionek A., Fuchs A., Schmidt P., Cremer S., Zysk M., Miltenyi S., Buck D.W., Schmitz J. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 2000, 165:6037-6046.
39. Haniffa M., Shin A., Bigley V., McGovern N., Teo P., See P., Wasan Pavandip S., Wang X.-N., Malinarich F., Malleret B., Larbi A., Tan P., Zhao H., Poidinger M., Pagan S., Cookson S., Dickinson R., Dimmick I., Jarrett Ruth F., Renia L., Tam J., Song C., Connolly J., Chan Jerry K.Y., Gehring A., Bertoletti A., Collin M., Ginhoux F. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 2012, 37:60-73.
40. Bonifazi P., D'Angelo C., Zagarella S., Zelante T., Bozza S., De Luca A., Giovannini G., Moretti S., Iannitti R.G., Fallarino F., Carvalho A., Cunha C., Bistoni F., Romani L. Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol. 2009, 3:193-205.
41. Collison A., Hatchwell L., Verrills N., Wark P.A.B., de Siqueira A.P., Tooze M., Carpenter H., Don A.S., Morris J.C., Zimmermann N., Bartlett N.W., Rothenberg M.E., Johnston S.L., Foster P.S., Mattes J. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat. Med. 2013, 19:232-237.
42. Huang Z.-Y., Kim M.-K., Kim-Han T.-H., Indik Z.K., Schreiber A.D. Effect of locally administered Syk siRNA on allergen-induced arthritis and asthma. Mol. Immunol. 2013, 53:52-59.
43. Zafra M.P., Mazzeo C., Gámez C., Marco A.R., de Zulueta A., Sanz V., Bilbao I., Ruiz-Cabello J., Zubeldia J.M., del Pozo V. Gene silencing of SOCS3 by siRNA intranasal delivery inhibits asthma phenotype in mice. PLoS One 2014, 9:1-11.
44. Wu S.-Y., Yu J.-S., Liu F.-T., Miaw S.-C., Wu-Hsieh B.A. Galectin-3 negatively regulates dendritic cell production of IL-23/IL-17-axis cytokines in infection by histoplasma capsulatum. J. Immunol. 2013, 190:3427-3437.
45. Fermin Lee A., Chen H.-Y., Wan L., Wu S.-Y., Yu J.-S., Huang A.C., Miaw S.-C., Hsu D.K., Wu-Hsieh B.A., Liu F.-T. Galectin-3 modulates Th17 responses by regulating dendritic cell cytokines. Am. J. Pathol. 2013, 183:1209-1222.
46. Okamura D.M., Pasichnyk K., Lopez-Guisa J.M., Collins S., Hsu D.K., Liu F.-T., Eddy A.A. Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis. Am. J. Physiol. Renal Physiol. 2011, 300:F245-F253.
47. Henderson N.C., Mackinnon A.C., Farnworth S.L., Kipari T., Haslett C., Iredale J.P., Liu F.-T., Hughes J., Sethi T. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am. J. Pathol. 2008, 172:288-298.
48. MacKinnon A.C., Farnworth S.L., Hodkinson P.S., Henderson N.C., Atkinson K.M., Leffler H., Nilsson U.J., Haslett C., Forbes S.J., Sethi T. Regulation of alternative macrophage activation by galectin-3. J. Immunol. 2008, 180:2650-2658.
49. S.S. Chen, RNA interference of galectin-3 expression and the methods of use thereof, US 2013/0072540 A1, USPTO (2013).
50. Harding H.P., Zhang Y., Zeng H., Novoa I., Lu P.D., Calfon M., Sadri N., Yun C., Popko B., Paules R., Stojdl D.F., Bell J.C., Hettmann T., Leiden J.M., Ron D. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 2003, 11:619-633.
51. Shalom-Feuerstein R., Cooks T., Raz A., Kloog Y. Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells. Cancer Res. 2005, 65:7292-7300.
52. Shimura T., Takenaka Y., Fukumori T., Tsutsumi S., Okada K., Hogan V., Kikuchi A., Kuwano H., Raz A. Implication of galectin-3 in Wnt signaling. Cancer Res. 2005, 65:3535-3537.
53. Saravanan C., Liu F.-T., Gipson I.K., Panjwani N. Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on α3β1 integrin. J. Cell Sci. 2009, 122:3684-3693.
54. Yang R.-Y., Hsu D.K., Liu F.-T. Expression of galectin-3 modulates T-cell growth and apoptosis. PNAS 1996, 93:6737-6742.
55. Cecchinelli B., Lavra L., Rinaldo C., Iacovelli S., Gurtner A., Gasbarri A., Ulivieri A., Del Prete F., Trovato M., Piaggio G., Bartolazzi A., Soddu S., Sciacchitano S. Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis. Mol. Cell. Biol. 2006, 26:4746-4757.
56. Fermino M.L., Dias F.C., Lopes C.D., Souza M.A., Cruz Â.K., Liu F.-T., Chammas R., Roque-Barreira M.C., Rabinovich G.A., Bernardes E.S. Galectin-3 negatively regulates the frequency and function of CD4+CD25+Foxp3+ regulatory T cells and influences the course of Leishmania major infection. Eur. J. Immunol. 2013, 43:1806-1817.
57. Ilarregui J.M., Croci D.O., Bianco G.A., Toscano M.A., Salatino M., Vermeulen M.E., Geffner J.R., Rabinovich G.A. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 2009, 10:981-991.
58. Hall Aisling O.H., Beiting Daniel P., Tato C., John B., Oldenhove G., Lombana Claudia G., Pritchard Gretchen H., Silver Jonathan S., Bouladoux N., Stumhofer Jason S., Harris Tajie H., Grainger J., Wojno Elia D.T., Wagage S., Roos David S., Scott P., Turka Laurence A., Cherry S., Reiner Steven L., Cua D., Belkaid Y., Elloso M.M., Hunter Christopher A. The cytokines interleukin 27 and interferon-γ promote distinct treg cell populations required to limit infection-induced pathology. Immunity 2012, 37:511-523.
59. Pennell L.M., Fish E.N. Immunoregulatory effects of interferon-β in suppression of Th17 cells. J. Interferon Cytokine Res. 2014, 34:333-341.
60. Peck A., Mellins E.D. Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 2010, 129:147-153.